Can a simpler, cheaper method for marking breast tumors work as well as ultrasound?
NCT ID NCT07716644
First seen Jul 21, 2026 · Last updated Jul 22, 2026 · Updated 1 time
Summary
This trial tests whether placing a small marker clip into a breast tumor without ultrasound guidance (using touch alone) is as accurate, safe, and cost-effective as using ultrasound. The study involves 50 women with palpable breast tumors who will receive neoadjuvant chemotherapy. The goal is to find a viable, lower-cost option for breast cancer care in low-resource settings.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- breast lesion clip placement (procedure)
- What this could lead to
- If blind clipping proves accurate and cost-effective, it could offer a practical alternative for breast cancer care in low-resource settings.
- What could go wrong
- This is a small, single-center trial, so results may not apply broadly. Blind clipping may be less accurate than ultrasound guidance.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Tertiary Care Hospitals, Faisalabad, Pakistan
Faisalābad, Punjab Province, 38000, Pakistan
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new pill slow advanced breast cancer better than standard hormone therapy?
- Could adding chemo help older breast cancer patients live longer? a major trial investigates.
- Diet and exercise may boost chemotherapy completion in breast cancer patients
- Saliva test could sharpen breast cancer risk prediction after abnormal biopsy
- AI reads MRI scans to predict who will benefit from chemo
- Could ultrasound screening catch breast cancer earlier in older women?